Callable Multi Barrier Reverse Convertible

Symbol: LAAJDU
ISIN: CH1424869308
Issuer:
UBS
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Price Time-delayed price
09.01.26
09:25:09
100.00 %
100.40 %
USD
Volume
70,000
10,000
nominal
Trading hours for this product: 9:15 – 17:15

Performance

Closing prev. day 100.20
Diff. absolute / % -0.20 -0.20%

Determined prices

Last Price 100.20 Volume 100,000
Time 16:48:25 Date 08/01/2026

More Product Information

Core Data

Name Callable Multi Barrier Reverse Convertible
ISIN CH1424869308
Valor 142486930
Symbol LAAJDU
Quotation in percent Yes
Coupon p.a. 22.00%
Coupon Premium 17.90%
Coupon Yield 4.10%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
COSI Product No
Exercise type American
Currency US Dollar
First Trading Date 25/04/2025
Date of maturity 27/04/2026
Last trading day 20/04/2026
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded No
Pricing Clean
Issuer UBS

Key data

Ask Price (basis for calculation) 100.3000
Maximum yield 5.98%
Maximum yield p.a. 20.02%
Sideways yield 5.98%
Sideways yield p.a. 20.02%

market maker quality Date: 08/01/2026

Average Spread 1.02%
Last Best Bid Price 99.35 %
Last Best Ask Price 100.20 %
Last Best Bid Volume 100,000
Last Best Ask Volume 100,000
Average Buy Volume 22,697
Average Sell Volume 22,697
Average Buy Value 22,529 USD
Average Sell Value 22,760 USD
Spreads Availability Ratio 93.63%
Quote Availability 99.16%

Underlyings

Name Pfizer Inc. Johnson & Johnson Moderna Inc.
ISIN US7170811035 US4781601046 US60770K1079
Cap 22.04 USD 153.91 USD 25.19 USD
Distance to Cap 3.23 51.74 8.68
Distance to Cap in % 12.78% 25.16% 25.63%
Is Cap Level reached No No No
Barrier 11.02 USD 76.955 USD 12.595 USD
Distance to Barrier 14.25 128.695 21.275
Distance to Barrier in % 56.39% 62.58% 62.81%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.